Hannah Beckwith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hannah Beckwith has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Edwina Anne Brown
Renal Department, Imperial College Healthcare NHS Trust, London, UK
4 shared publications Edwina A. Brown
Renal Department, Imperial College Healthcare NHS Trust, London, United Kingdom
3 shared publicationsH. Terence Cook
Department of Immunology and Inflammation, Imperial College London, London, UK
3 shared publications- Ailish Nimmo
NHS Bristol Foundation Trust, Bristol, UK; University of Bristol, Bristol, UK
2 shared publications Anamika Adwaney
Renal Department, Imperial College Healthcare NHS Trust, London, UK
2 shared publicationsCharles D. Pusey
Department of Immunology and Inflammation, Imperial College London, London, UK
2 shared publications
Latest Publications
- Open Access
Maternal APOL1 Genotypes and Preeclampsia Risk
Background: APOL1 risk alleles are prevalent in individuals of West African ancestry and associated with increased risk of kidney disease. Although preeclampsia disproportionately affects women of Black ethnic backgrounds, evidence linking APOL1 alleles to preeclampsia remains conflicting. Objectives: The purpose of this study was to explore whether maternal APOL1 alleles contribute to preeclampsia risk and associated adverse pregnancy outcomes. Study design: We conducted a nested case-control study of 5210 pregnant women, including 745 preeclampsia cases and 949 controls of Black self-reported ethnicity, 1385 preeclampsia cases and 2131 controls of White self-reported ethnicity. APOL1 G1 and G2 risk alleles were directly genotyped on the Illumina Infinium® Global Screening Array. Associations with preeclampsia, early preeclampsia, recurrent preeclampsia, birthweight centiles and gestational age at delivery were examined using regression models assuming a recessive mode of inheritance with adjustment for established risk factors and stratification by self-reported ethnicity and genetically-determined ancestry. Results: Presence of APOL1 risk alleles was almost exclusively observed in women of Black self-reported ethnicity. 168/949 controls (17.7%) and 133/745 cases (17.9%) carried two APOL1 risk alleles, and these women did not have a significantly increased risk of preeclampsia compared to those with zero or one APOL1 risk alleles in adjusted analyses (OR 1.00, 95% CI 0.76-1.29, p=0.972). When restricting analysis to women of Black self-reported ethnicity only, no association was observed between APOL1 genotype and preeclampsia risk (adjusted OR 0.94, 95% CI 0.61-1.25, p=0.673). When restricting analysis to women of pan-African genetically-determined ancestry only, also no association was observed between APOL1 genotype and preeclampsia risk (adjusted OR 1.00, 95% CI 0.76-1.32). No associations were found between number of APOL1 risk alleles and early preeclampsia, recurrent preeclampsia, birthweight centile or gestational age at delivery after adjustment for established risk factors and stratification by self-reported ethnicity or genetically-determined ancestry. Conclusions: Maternal APOL1 risk alleles do not independently influence preeclampsia risk or related adverse outcomes in a multi-ethnic pregnancy study. Future studies should examine whether fetal APOL1 genotypes, alone or in interaction with maternal genotypes, contribute to preeclampsia risk. At a Glance: A. Why was this study conducted?: APOL1 risk alleles are prevalent in West African ancestry populations and associated with kidney disease Preeclampsia disproportionately affects women of Black ethnicity Previous studies showed conflicting evidence linking maternal APOL1 alleles to preeclampsia risk B. What are the key findings?: In 5,210 multi-ethnic women, maternal APOL1 risk alleles showed no independent association with preeclampsia or related adverse outcomes Associations in unadjusted analyses reflected West African genetic ancestry rather than direct causation C. What does this study add to what is already known?: Largest genetic study of maternal APOL1 and preeclampsia in women of Black ethnicity (745 cases) Demonstrates APOL1 alleles serve as ancestry markers rather than causal variants Highlights need to examine fetal genotypes and gene-environment interactions
Open AccessMaternal APOL1 Genotypes and Preeclampsia Risk
Background: APOL1 risk alleles are prevalent in individuals of West African ancestry and associated with increased risk of kidney disease. Although preeclampsia disproportionately affects women of Black ethnic backgrounds, evidence linking APOL1 alleles to preeclampsia remains conflicting. Objectives: The purpose of this study was to explore whether maternal APOL1 alleles contribute to preeclampsia risk and associated adverse pregnancy outcomes. Study design: We conducted a nested case-control study of 5210 pregnant women, including 745 preeclampsia cases and 949 controls of Black self-reported ethnicity, 1385 preeclampsia cases and 2131 controls of White self-reported ethnicity. APOL1 G1 and G2 risk alleles were directly genotyped on the Illumina Infinium® Global Screening Array. Associations with preeclampsia, early preeclampsia, recurrent preeclampsia, birthweight centiles and gestational age at delivery were examined using regression models assuming a recessive mode of inheritance with adjustment for established risk factors and stratification by self-reported ethnicity and genetically-determined ancestry. Results: Presence of APOL1 risk alleles was almost exclusively observed in women of Black self-reported ethnicity. 168/949 controls (17.7%) and 133/745 cases (17.9%) carried two APOL1 risk alleles, and these women did not have a significantly increased risk of preeclampsia compared to those with zero or one APOL1 risk alleles in adjusted analyses (OR 1.00, 95% CI 0.76-1.29, p=0.972). When restricting analysis to women of Black self-reported ethnicity only, no association was observed between APOL1 genotype and preeclampsia risk (adjusted OR 0.94, 95% CI 0.61-1.25, p=0.673). When restricting analysis to women of pan-African genetically-determined ancestry only, also no association was observed between APOL1 genotype and preeclampsia risk (adjusted OR 1.00, 95% CI 0.76-1.32). No associations were found between number of APOL1 risk alleles and early preeclampsia, recurrent preeclampsia, birthweight centile or gestational age at delivery after adjustment for established risk factors and stratification by self-reported ethnicity or genetically-determined ancestry. Conclusions: Maternal APOL1 risk alleles do not independently influence preeclampsia risk or related adverse outcomes in a multi-ethnic pregnancy study. Future studies should examine whether fetal APOL1 genotypes, alone or in interaction with maternal genotypes, contribute to preeclampsia risk. At a Glance: A. Why was this study conducted?: APOL1 risk alleles are prevalent in West African ancestry populations and associated with kidney disease Preeclampsia disproportionately affects women of Black ethnicity Previous studies showed conflicting evidence linking maternal APOL1 alleles to preeclampsia risk B. What are the key findings?: In 5,210 multi-ethnic women, maternal APOL1 risk alleles showed no independent association with preeclampsia or related adverse outcomes Associations in unadjusted analyses reflected West African genetic ancestry rather than direct causation C. What does this study add to what is already known?: Largest genetic study of maternal APOL1 and preeclampsia in women of Black ethnicity (745 cases) Demonstrates APOL1 alleles serve as ancestry markers rather than causal variants Highlights need to examine fetal genotypes and gene-environment interactions
- 2 September 2025
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 46 (3) , 261-264
Epidemiology of peritoneal dialysis exit site infections: Does sex play a role?
Identifying risk factors that pre-dispose people on peritoneal dialysis (PD) to develop exit site infections (ESIs) may help improve prevention and treatment. Given the differences anatomically, hormonally and of the microbiota profile between males and females, we hypothesised that there is a difference in ESI incidence, outcomes, and the epidemiology of organism-specific ESI between males and females. This study was a retrospective case note review of all PD patients at our centre between 2012 and 2024. Of the 486 patients on PD, 202 (42%) were female and 273 positive swabs from 151 patients were identified (0.18 patient episodes/year). We found no statistically significant difference in the incidence of ESI between sexes in our cohort. Gram-positive organisms accounted for 126/273 (46.2%) of all ESI swabs, suggesting that current empiric antibiotic therapy potentially offers effective treatment for less than half of ESI only. We found significant morbidity from ESI: 39 (14%) patients developed peritonitis and 40 (15%) required catheter removal. Sex had no influence on ESI incidence, microbiology of infection or outcome.
- 2 September 2025
- Published by SAGE Publications in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Vol. 46 (3) , 261-264
Epidemiology of peritoneal dialysis exit site infections: Does sex play a role?
Identifying risk factors that pre-dispose people on peritoneal dialysis (PD) to develop exit site infections (ESIs) may help improve prevention and treatment. Given the differences anatomically, hormonally and of the microbiota profile between males and females, we hypothesised that there is a difference in ESI incidence, outcomes, and the epidemiology of organism-specific ESI between males and females. This study was a retrospective case note review of all PD patients at our centre between 2012 and 2024. Of the 486 patients on PD, 202 (42%) were female and 273 positive swabs from 151 patients were identified (0.18 patient episodes/year). We found no statistically significant difference in the incidence of ESI between sexes in our cohort. Gram-positive organisms accounted for 126/273 (46.2%) of all ESI swabs, suggesting that current empiric antibiotic therapy potentially offers effective treatment for less than half of ESI only. We found significant morbidity from ESI: 39 (14%) patients developed peritonitis and 40 (15%) required catheter removal. Sex had no influence on ESI incidence, microbiology of infection or outcome.
- Open Access
- 24 March 2025
- Published by Elsevier in Kidney International Reports
- Vol. 10 (6) , 2058-2061
Kidney Complement Immunohistochemistry in Thrombotic Microangiopathy Subtypes
- 24 March 2025
- Published by Elsevier in Kidney International Reports
- Vol. 10 (6) , 2058-2061
Open AccessKidney Complement Immunohistochemistry in Thrombotic Microangiopathy Subtypes
- 14 March 2024
- Published by Cassyni
Older Age and Advanced Kidney Disease
Our leading expert will use 4 patient stories to illustrate learning points in ethics, frailty, dementia, supportive care and patient expectations.Schedule:1. 14:00-14:20 Ethics Focused Patient Story 2. 14:20-14:40 Frailty and Advanced Kidney Care and Dialysis 3. 14:40-15:00 Supportive Assisted Peritoneal Dialysis and Dementia 4. 15:00-15:20 Inpatient Care and Patient Expectations 5. 15:20 General Discussion with Delegate QuestionsEthics Focused Patient StoryA lot of the literature examines ethical challenges in palliative care from the theoretical level and describes the implications these theories have for bedside practice. Very little research has looked at what the landscape looks like at the bedside and what that might mean for the usefulness of the various theoretical perspectives for guiding day-to-day clinical practice. Guy will use a patient story to illustrate his research in this area.
- 14 March 2024
- Published by Cassyni
Older Age and Advanced Kidney Disease
Our leading expert will use 4 patient stories to illustrate learning points in ethics, frailty, dementia, supportive care and patient expectations.Schedule:1. 14:00-14:20 Ethics Focused Patient Story 2. 14:20-14:40 Frailty and Advanced Kidney Care and Dialysis 3. 14:40-15:00 Supportive Assisted Peritoneal Dialysis and Dementia 4. 15:00-15:20 Inpatient Care and Patient Expectations 5. 15:20 General Discussion with Delegate QuestionsEthics Focused Patient StoryA lot of the literature examines ethical challenges in palliative care from the theoretical level and describes the implications these theories have for bedside practice. Very little research has looked at what the landscape looks like at the bedside and what that might mean for the usefulness of the various theoretical perspectives for guiding day-to-day clinical practice. Guy will use a patient story to illustrate his research in this area.
- 23 August 2023
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 19 (3) , 377-384
Delivering Person-Centered Peritoneal Dialysis
Peritoneal dialysis (PD) enables people to have a home-based therapy, permitting greater autonomy for individuals along with enhanced treatment satisfaction compared with in-center dialysis care. The burden of treatment on PD, however, remains considerable and underpins the need for person-centered care. This reflects the need to address the patient as a person with needs and preferences beyond just the medical perspective. Shared decision making is central to the recent International Society for Peritoneal Dialysis recommendations for prescribing PD, balancing the potential benefits of PD on patient well-being with the burden associated with treatment. This review considers the role of high-quality goal-directed prescribing, incremental dialysis, and remote patient monitoring in reducing the burden of dialysis, including an approach to implementing incremental PD. Although patient-related outcomes are important in assessing the response to treatment and, particularly life participation, the corollary of dialysis burden, there are no clear routes to the clinical implementation of patient-related outcome measures. Delivering person-centered care is dependent on treating people both as individuals and as equal partners in their care.
- 23 August 2023
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 19 (3) , 377-384
Delivering Person-Centered Peritoneal Dialysis
Peritoneal dialysis (PD) enables people to have a home-based therapy, permitting greater autonomy for individuals along with enhanced treatment satisfaction compared with in-center dialysis care. The burden of treatment on PD, however, remains considerable and underpins the need for person-centered care. This reflects the need to address the patient as a person with needs and preferences beyond just the medical perspective. Shared decision making is central to the recent International Society for Peritoneal Dialysis recommendations for prescribing PD, balancing the potential benefits of PD on patient well-being with the burden associated with treatment. This review considers the role of high-quality goal-directed prescribing, incremental dialysis, and remote patient monitoring in reducing the burden of dialysis, including an approach to implementing incremental PD. Although patient-related outcomes are important in assessing the response to treatment and, particularly life participation, the corollary of dialysis burden, there are no clear routes to the clinical implementation of patient-related outcome measures. Delivering person-centered care is dependent on treating people both as individuals and as equal partners in their care.
- Open Access
- 16 June 2023
- Published by Elsevier in Kidney Medicine
- Vol. 5 (8) , 100687
Perceived Life Expectancy Among Dialysis Recipients: A Scoping Review
- 16 June 2023
- Published by Elsevier in Kidney Medicine
- Vol. 5 (8) , 100687
Open AccessPerceived Life Expectancy Among Dialysis Recipients: A Scoping Review
- Open Access
- 4 April 2023
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 38 (7) , 1580-1582
Health-related quality of life in kidney transplant recipients: can we do better?
Hannah Beckwith, Edwina A Brown; Health-related quality of life in kidney transplant recipients: can we do better?, Nephrology Dialysis Transplantation, , gfad0
- 4 April 2023
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 38 (7) , 1580-1582
Open AccessHealth-related quality of life in kidney transplant recipients: can we do better?
Hannah Beckwith, Edwina A Brown; Health-related quality of life in kidney transplant recipients: can we do better?, Nephrology Dialysis Transplantation, , gfad0
- Open Access
- 3 September 2022
- Published by Elsevier in Kidney International Reports
- Vol. 7 (11) , 2421-2430
Gender Differences in Experiences and Expectations of Hemodialysis in a Frail and Seriously Unwell Patient Population
- 3 September 2022
- Published by Elsevier in Kidney International Reports
- Vol. 7 (11) , 2421-2430
Open AccessGender Differences in Experiences and Expectations of Hemodialysis in a Frail and Seriously Unwell Patient Population
- Open Access
- 16 June 2022
- Published by Elsevier in Seminars in Nephrology
- Vol. 42 (2) , 185-196
Sex and Gender in Glomerular Disease
- 16 June 2022
- Published by Elsevier in Seminars in Nephrology
- Vol. 42 (2) , 185-196
Open AccessSex and Gender in Glomerular Disease
- 16 February 2022
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 99 (1170) , 350-357
Demographics, distribution and experiences of UK clinical academic trainees using GMC NTS Survey data
Involvement in research plays an integral role in the delivery of high-quality patient care, benefitting doctors, patients and employers. It is important that access to clinical academic training opportunities are inclusive and equitable. To better understand the academic trainee population, distribution of academic posts and their reported experience of clinical training, we analysed 53 477 anonymous responses from General Medical Council databases and the 2019 National Training Survey. Academic trainees are more likely to be men, and the gender divide begins prior to graduation. There are very low numbers of international medical graduates and less than full-time academic trainees. A small number of UK universities produce a greater prevalence of doctors successfully appointed to academic posts; subsequent academic training also clusters around these institutions. At more senior levels, academic trainees are significantly more likely to be of white ethnicity, although among UK graduates, no ethnicity differences were seen. Foundation academic trainees report a poorer experience of some aspects of their clinical training placements, with high workloads reported by all academic trainees. Our work highlights important disparities in the demographics of the UK clinical academic trainee population and raises concerns that certain groups of doctors face barriers accessing and progressing in UK academic training pathways.
- 16 February 2022
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 99 (1170) , 350-357
Demographics, distribution and experiences of UK clinical academic trainees using GMC NTS Survey data
Involvement in research plays an integral role in the delivery of high-quality patient care, benefitting doctors, patients and employers. It is important that access to clinical academic training opportunities are inclusive and equitable. To better understand the academic trainee population, distribution of academic posts and their reported experience of clinical training, we analysed 53 477 anonymous responses from General Medical Council databases and the 2019 National Training Survey. Academic trainees are more likely to be men, and the gender divide begins prior to graduation. There are very low numbers of international medical graduates and less than full-time academic trainees. A small number of UK universities produce a greater prevalence of doctors successfully appointed to academic posts; subsequent academic training also clusters around these institutions. At more senior levels, academic trainees are significantly more likely to be of white ethnicity, although among UK graduates, no ethnicity differences were seen. Foundation academic trainees report a poorer experience of some aspects of their clinical training placements, with high workloads reported by all academic trainees. Our work highlights important disparities in the demographics of the UK clinical academic trainee population and raises concerns that certain groups of doctors face barriers accessing and progressing in UK academic training pathways.